Table 2.
The information of preoperative coagulation characteristics.
| Characteristics | Aspirin | Clopidogrel | DAPT | |||
|---|---|---|---|---|---|---|
| PR | NPR | PR | NPR | PR | NPR | |
| n = 17 | n = 111 | n = 2 | n = 13 | n = 21 | n = 33 | |
| Platelet count ↓†-no. (%) | 1 (5.9%) | 1 (0.9%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| APTT ↑†-no. (%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| PT ↑†-no. (%) | 1 (5.9%) | 11 (9.9%) | 0 (0.0%) | 0 (0.0%) | 2 (9.5%) | 4 (12.1%) |
| Fbg ↓†-no. (%) | 3 (17.6%) | 5 (4.5%) | 0 (0.0%) | 0 (0.0%) | 5 (23.8%) | 0 (0.0%) |
| CK-MA -no. (%) | ||||||
| >70 mm | 0 (0.0%) | 7 (6.3%) | 0 (0.0%) | 2 (15.4%) | 1 (4.8%) | 5 (15.2%) |
| 50~70 mm | 11 (64.7%) | 98 (88.3%) | 2 (100%) | 11 (84.6%) | 15 (71.4%) | 27 (81.8%) |
| <50 mm | 6 (35.3%) | 6 (5.4%) | 0 (0.0%) | 0 (0.0%) | 5 (23.8%) | 1 (3.0%) |
| AA% -median (IQR) | 71.1 (51.8–77.9) | 42.7 (27.4–54.4) | N/A | N/A | 60.8 (53.8–70.4) | 52.6 (36.1–58.6) |
| ADP% -median (IQR) | N/A | N/A | 85.8 (79.3–92.3) | 42.3 (31.4–52.1) | 62.3 (48.7–64.3) | 52.9 (44.0–74.8) |
N/A, not this data.
†
Platelet count ↓, platelet count <50 ×109; APTT ↑, APTT prolongs by ≥ 10 s; PT ↑, PT prolongs by ≥ 3 s; Fbg ↓, Fbg <1.5 g/l.
PR, postoperative rebleeding; NPR, no postoperative rebleeding; DAPT, dual antiplatelet treatment; APTT, activated partial thromboplastin time; PT, prothrombin time; Fbg, fibrinogen; CK-MA, citric acid kaolin-tracing maximum amplitude; AA%, the inhibition caused by aspirin; ADP%, the inhibition caused by clopidogrel.